Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Strategies to Increase the Oral Bioavailability of Nucleoside Analogs

Author(s): Muriel Lalanne, Karine Andrieux and Patrick Couvreur

Volume 16 , Issue 11 , 2009

Page: [1391 - 1399] Pages: 9

DOI: 10.2174/092986709787846550

Price: $65

Abstract

Nucleoside analogs are first line chemotherapy in various severe diseases: AIDS (acquired immunodeficiency disease syndrome), cytomegalovirus infections, cancer etc. However, most of these compounds suffer from poor bioavailability via oral route. In order to get around this drawback, researchers have imagined many strategies including drug metabolism inhibitors, bio adhesive nanoparticles, amino ester prodrugs, as well as enhancing absorption by increasing drug lipophilicity. This paper illustrated these approaches by developing their application to some nucleoside analogs. Moreover, some of these strategies were very successful and some resulting compounds are now approved by FDA (Food and Drug Administration).

Keywords: Nucleoside analogs, oral absorption, prodrug


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy